EGFR Overview
| Cat No. | Product Name | CAS No. | Purity | Order |
|---|---|---|---|---|
| I019823 | TAS6417 | 1661854-97-2 | ≥ 95% | Inquiry |
| I017547 | EGFR-IN-11 | 2463200-44-2 | ≥ 95% | Inquiry |
| I017460 | Gefitinib D8 | 857091-32-8 | ≥ 95% | Inquiry |
| I014281 | Afatinib impurity 11 | 1402086-20-7 | ≥ 95% | Inquiry |
| I013761 | EAI045 | 1942114-09-1 | ≥ 95% | Inquiry |
| I013157 | AG 555 | 133550-34-2 | ≥ 95% | Inquiry |
| R067120 | Gefitinib-d6 | 1228664-49-0 | ≥ 95% | Inquiry |
| I011589 | EGFR Inhibitor | 879127-07-8 | ≥ 95% | Inquiry |
| I011591 | Lapatinib Ditosylate monohydrate | 388082-78-8 | ≥ 95% | Inquiry |
| I006687 | Daphnetin | 486-35-1 | ≥ 95% | Inquiry |
| I008931 | Pyrotinib | 1269662-73-8 | ≥ 95% | Inquiry |
| I007618 | Lapatinib ditosylate | 388082-77-7 | ≥ 95% | Inquiry |
| I007619 | Lapatinib (free base) | 231277-92-2 (free base) | ≥ 95% | Inquiry |
| I006704 | Erlotinib free base | 183321-74-6 (free base) | ≥ 95% | Inquiry |
| I005483 | Canertinib | 289499-45-2 (HCl salt) | ≥ 95% | Inquiry |
| I001281 | Afatinib dimaleate | 850140-73-7 (dimaleate) | ≥ 95% | Inquiry |
| I005096 | Afatinib | 850140-72-6 | ≥ 95% | Inquiry |
| I004621 | Neratinib | 698387-09-6 | ≥ 95% | Inquiry |
| I003720 | Butein | 487-52-5 | ≥ 95% | Inquiry |
| I003579 | Genistein | 446-72-0 | ≥ 95% | Inquiry |
| I003412 | CP-724714 | 383432-38-0 | ≥ 95% | Inquiry |
| I002998 | Canertinib (CI-1033, PD-183805) | 289499-45-2 | ≥ 95% | Inquiry |
| I002916 | Canertinib | 267243-28-7 | ≥ 95% | Inquiry |
| I002626 | WHI-P154 | 211555-04-3 | ≥ 95% | Inquiry |
| I002483 | PD168393 | 194423-15-9 | ≥ 95% | Inquiry |